Trial Information

Summary: Mycosis Fungoides- Cutaneous t-cell lymphoma

New York University School of Medicine Department of Dermatology is currently looking for subjects to participate in a research study of an experimental drug for patients with Mycosis Fungoides.

This is a 22-week, open-label study. Study drug and procedures will be made available to you at no cost. Compensation will be provided for travel expenses.

To qualify, you must:

  • Be 18 years of age or older
  • Be diagnosed with Mycosis Fungoides stage IB to IVB
  • Not be pregnant or breastfeeding
  • Have not received combination chemotherapy treatment within the last two years
  • Not treated with more than three regiments of single agent chemotherapy
  • Not have the HIV infection or AIDS
  • Not have Hepatitis B or Hepatitis C

Contact:

Biomedical Research Alliance of New York
New York University School of Medicine
Department of Dermatology
560 First Avenue
New York, NY 10016
Telephone: 212-263-6881
Email:

Profile Page: Biomedical Research Alliance of New York, New York, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:06 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA